Research ArticleClinical Studies
Prognostic Value of Thyroid Transcription Factor-1 Expression in Patients with Advanced Lung Adenocarcinoma
ROLANDAS ZABLOCKIS, EDVARDAS ŽURAUSKAS, EDVARDAS DANILA and VYGANTAS GRUSLYS
In Vivo November 2018, 32 (6) 1571-1579; DOI: https://doi.org/10.21873/invivo.11416
ROLANDAS ZABLOCKIS
1Clinic of Chest Diseases, Immunology and Allergology, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
2Centre of Pulmonology and Allergology, Santaros Klinikos, Vilnius University Hospital, Vilnius, Lithuania
EDVARDAS ŽURAUSKAS
3Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania
4National Centre of Pathology, Affiliate of Santaros Klinikos, Vilnius University Hospital, Vilnius, Lithuania
EDVARDAS DANILA
1Clinic of Chest Diseases, Immunology and Allergology, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
2Centre of Pulmonology and Allergology, Santaros Klinikos, Vilnius University Hospital, Vilnius, Lithuania
VYGANTAS GRUSLYS
1Clinic of Chest Diseases, Immunology and Allergology, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
2Centre of Pulmonology and Allergology, Santaros Klinikos, Vilnius University Hospital, Vilnius, Lithuania
In this issue
In Vivo
Vol. 32, Issue 6
November-December 2018
Prognostic Value of Thyroid Transcription Factor-1 Expression in Patients with Advanced Lung Adenocarcinoma
ROLANDAS ZABLOCKIS, EDVARDAS ŽURAUSKAS, EDVARDAS DANILA, VYGANTAS GRUSLYS
In Vivo Nov 2018, 32 (6) 1571-1579; DOI: 10.21873/invivo.11416
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.